7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine

C144H165N47O3 — CID 158967299

IUPAC7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
SMILESCC(C)c1cnnc(Nc2ccc3ncc(-c4cn(C)nc4CO)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCCN5CCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cccnc5)c4)cc3n2)c1.CCN(CC)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1nn(CCCN2CCOCC2)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C27H34N8O.C25H32N8.C24H28N8O.C24H28N8.C24H22N8.C20H21N7O/c1-4-23-22(18-35(33-23)9-5-8-34-10-12-36-13-11-34)21-14-25-24(28-16-21)6-7-26(30-25)31-27-15-20(19(2)3)17-29-32-27;1-5-32(6-2)10-7-11-33-17-21(16-28-33)20-12-23-22(26-14-20)8-9-24(29-23)30-25-13-19(18(3)4)15-27-31-25;1-17(2)18-12-24(30-26-14-18)29-23-4-3-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)6-5-31-7-9-33-10-8-31;1-17(2)18-12-24(30-26-14-18)29-23-6-5-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)10-4-9-31-7-3-8-31;1-16(2)18-9-24(31-27-12-18)30-23-6-5-21-22(29-23)8-19(11-26-21)20-13-28-32(15-20)14-17-4-3-7-25-10-17;1-12(2)13-7-20(25-22-9-13)24-19-5-4-16-17(23-19)6-14(8-21-16)15-10-27(3)26-18(15)11-28/h6-7,14-19H,4-5,8-13H2,1-3H3,(H,30,31,32);8-9,12-18H,5-7,10-11H2,1-4H3,(H,29,30,31);3-4,11-17H,5-10H2,1-2H3,(H,28,29,30);5-6,11-17H,3-4,7-10H2,1-2H3,(H,28,29,30);3-13,15-16H,14H2,1-2H3,(H,29,30,31);4-10,12,28H,11H2,1-3H3,(H,23,24,25)
InChIKeyJNJFIUZWSUOSQB-UHFFFAOYSA-N
MW2602.23 g/mol
LogP24.82
Rot. Bonds45

About 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine

7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine (PubChem CID 158967299) has the molecular formula C144H165N47O3 and a molecular weight of 2602.23 g/mol. Its IUPAC name is 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine.

Molecular Properties

Compound Name7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
PubChem CID158967299
Molecular FormulaC144H165N47O3
Molecular Weight2602.23 g/mol
Exact Mass2600.42
IUPAC Name7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
SMILESCC(C)c1cnnc(Nc2ccc3ncc(-c4cn(C)nc4CO)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCCN5CCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cccnc5)c4)cc3n2)c1.CCN(CC)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1nn(CCCN2CCOCC2)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C27H34N8O.C25H32N8.C24H28N8O.C24H28N8.C24H22N8.C20H21N7O/c1-4-23-22(18-35(33-23)9-5-8-34-10-12-36-13-11-34)21-14-25-24(28-16-21)6-7-26(30-25)31-27-15-20(19(2)3)17-29-32-27;1-5-32(6-2)10-7-11-33-17-21(16-28-33)20-12-23-22(26-14-20)8-9-24(29-23)30-25-13-19(18(3)4)15-27-31-25;1-17(2)18-12-24(30-26-14-18)29-23-4-3-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)6-5-31-7-9-33-10-8-31;1-17(2)18-12-24(30-26-14-18)29-23-6-5-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)10-4-9-31-7-3-8-31;1-16(2)18-9-24(31-27-12-18)30-23-6-5-21-22(29-23)8-19(11-26-21)20-13-28-32(15-20)14-17-4-3-7-25-10-17;1-12(2)13-7-20(25-22-9-13)24-19-5-4-16-17(23-19)6-14(8-21-16)15-10-27(3)26-18(15)11-28/h6-7,14-19H,4-5,8-13H2,1-3H3,(H,30,31,32);8-9,12-18H,5-7,10-11H2,1-4H3,(H,29,30,31);3-4,11-17H,5-10H2,1-2H3,(H,28,29,30);5-6,11-17H,3-4,7-10H2,1-2H3,(H,28,29,30);3-13,15-16H,14H2,1-2H3,(H,29,30,31);4-10,12,28H,11H2,1-3H3,(H,23,24,25)
InChIKeyJNJFIUZWSUOSQB-UHFFFAOYSA-N
XLogP24.82
TPSA553.00 Ų
H-Bond Donors7
H-Bond Acceptors50
Rotatable Bonds45
Heavy Atoms194
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002602.23
LogP ≤ 524.82
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1050

Analyze 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 118497408
4-[3-[4-(6-chloro-1,5-naphthyridin-3-yl)-3-ethylpyrazol-1-yl]propyl]morpholine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 157311173
7-(1-methyl-3-morpholin-4-ylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 90289306
7-[1-methyl-3-[[methyl(pyridin-3-yl)amino]methyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 118510246
[5-[[4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-1-yl]methyl]-2-pyridinyl]methanol
CID 118504052
7-[1-[3-[methyl(2,2,2-trifluoroethyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 90288959
N-(5-propan-2-ylpyridazin-3-yl)-7-[1-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]pyrazol-4-yl]-1,5-naphthyridin-2-amine
CID 90289160
7-[1-[2-(2-oxa-6-azaspiro[3.3]heptan-6-yl)ethyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 90289058
1-morpholin-4-yl-2-[4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-1-yl]ethanone
CID 118504159
7-[1-(oxan-4-ylmethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 118510149
7-[1-[3-(3-butoxyazetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 90289166
7-[1-[(6-methoxy-2-pyridinyl)methyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
CID 90288621

Frequently Asked Questions

What is the IUPAC name of 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The IUPAC name of 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine (CID 158967299) is 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine.
What is the SMILES notation for 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The canonical SMILES for 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine is CC(C)c1cnnc(Nc2ccc3ncc(-c4cn(C)nc4CO)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCCN5CCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CCN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cccnc5)c4)cc3n2)c1.CCN(CC)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1nn(CCCN2CCOCC2)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1.
What is the InChIKey of 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The InChIKey is JNJFIUZWSUOSQB-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H34N8O.C25H32N8.C24H28N8O.C24H28N8.C24H22N8.C20H21N7O/c1-4-23-22(18-35(33-23)9-5-8-34-10-12-36-13-11-34)21-14-25-24(28-16-21)6-7-26(30-25)31-27-15-20(19(2)3)17-29-32-27;1-5-32(6-2)10-7-11-33-17-21(16-28-33)20-12-23-22(26-14-20)8-9-24(29-23)30-25-13-19(18(3)4)15-27-31-25;1-17(2)18-12-24(30-26-14-18)29-23-4-3-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)6-5-31-7-9-33-10-8-31;1-17(2)18-12-24(30-26-14-18)29-23-6-5-21-22(28-23)11-19(13-25-21)20-15-27-32(16-20)10-4-9-31-7-3-8-31;1-16(2)18-9-24(31-27-12-18)30-23-6-5-21-22(29-23)8-19(11-26-21)20-13-28-32(15-20)14-17-4-3-7-25-10-17;1-12(2)13-7-20(25-22-9-13)24-19-5-4-16-17(23-19)6-14(8-21-16)15-10-27(3)26-18(15)11-28/h6-7,14-19H,4-5,8-13H2,1-3H3,(H,30,31,32);8-9,12-18H,5-7,10-11H2,1-4H3,(H,29,30,31);3-4,11-17H,5-10H2,1-2H3,(H,28,29,30);5-6,11-17H,3-4,7-10H2,1-2H3,(H,28,29,30);3-13,15-16H,14H2,1-2H3,(H,29,30,31);4-10,12,28H,11H2,1-3H3,(H,23,24,25).
What are the key properties of 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine has a molecular weight of 2602.23 g/mol, XLogP of 24.82, 45 rotatable bonds, 7 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[1-[3-(azetidin-1-yl)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-(diethylamino)propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[3-ethyl-1-(3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;[1-methyl-4-[6-[(5-propan-2-ylpyridazin-3-yl)amino]-1,5-naphthyridin-3-yl]pyrazol-3-yl]methanol;7-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyridin-3-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine is sourced from PubChem (CID 158967299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).